EMERYVILLE, Calif., March 17,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a
leading synthetic biotechnology company accelerating the world's
transition to sustainable consumption through its Lab-to-Market™
technology platform today announced that management will
participate in a fireside chat at the Jefferies Virtual Synthetic
Biology Week on Wednesday, March 23,
2022, at 2:00 pm ET.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the company's
website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ technology platform. This Amyris platform leverages
state-of-the-art machine learning, robotics and artificial
intelligence, enabling the company to rapidly bring new innovation
to market at commercial scale. Amyris ingredients are included in
over 20,000 products from the world's top brands, reaching more
than 300 million consumers. Amyris also owns and operates a family
of consumer brands that is constantly evolving to meet the growing
demand for sustainable, effective and accessible products. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-to-participate-in-the-jefferies-virtual-synthetic-biology-week-301504484.html
SOURCE Amyris, Inc.